beta-lactams has been researched along with Cronobacter Infections in 289 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (3.46) | 18.7374 |
1990's | 10 (3.46) | 18.2507 |
2000's | 84 (29.07) | 29.6817 |
2010's | 166 (57.44) | 24.3611 |
2020's | 19 (6.57) | 2.80 |
Authors | Studies |
---|---|
Bitome Essono, PY; Bretagnolle, F; Godreuil, S; Mabika Mabika, A; Mbehang Nguema, PP; Muandze Nzambe, JU; Ndong Atome, GR; Obague Mbeang, JC; Onanga, R; Tewa, JJ | 1 |
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
Cai, Y; Wang, J; Wang, Y; Xiao, Q; Xu, J; Zhang, H; Zhu, M | 1 |
Chen, L; He, XP; Hong, SJ; Hua, J; Jing, RC; Luo, XY; Xue, HW; Yuan, CY; Yue, Y | 1 |
Brintz, BJ; Brown, DG; Earl, AM; Harris, JB; LaRocque, RC; Leung, DT; Oliver, E; Pender, MA; Rao, SR; Ryan, ET; Sridhar, S; Turbett, SE; Worby, CJ | 1 |
Chan, EWY; Cheng, VC; Chui, CSL; Cowling, BJ; Fan, M; Li, PH; Tun, HM; Wong, ICK; Wong, SC; Wu, P; Yu, Q | 1 |
Liu, J; Luo, Z; Wang, Y; Wu, D; Yang, X; Zhang, L; Zhao, G | 1 |
Bogiel, T; Gospodarek-Komkowska, E; Sêkowska, A; Woźniak, M | 1 |
Garner, OB; Ismagilov, RF; Liaw, EJ; Savela, ES; Schoepp, NG; Winnett, A | 1 |
Craft, DW; England, MR; Hale, CM; Lesher, MD; Myers, DS; Wijetunge, DSS | 1 |
Bai, Y; Li, R; Shen, C; Wang, C; Zhang, J | 1 |
De Angelis, G; Del Giacomo, P; Posteraro, B; Sanguinetti, M; Tumbarello, M | 1 |
Chang, NN; Khader, K; Spivak, ES; Stevens, VW; Sutton, JD; Timbrook, TT | 1 |
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
Boyd, A; Linde, I; Matser, A; Prins, JM; Prins, M; van Bilsen, WPH; van Dam, AP; van Duijnhoven, YTHP; van Dulm, E | 1 |
Bassetti, M; Berruti, M; Giacobbe, DR; Russo, A; Vena, A | 1 |
Bartoletti, M; Bussini, L; Gatti, M; Giannella, M; Ianniruberto, S; Malosso, P; Pancaldi, L; Pascale, R; Paul, M; Rebuffi, C; Scudeller, L; Tedeschi, S; Viale, P | 1 |
Aruhomukama, D; Bulafu, D; Chaplain, D; Joloba, M; Kidenya, B; Mboowa, G; Mshana, S; Seni, J; Sserwadda, I; Wewedru, I | 1 |
Gibble, A; Huang, A; Sapozhnikov, J; Zeeck, K | 1 |
Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ | 1 |
Ceccarelli, M; D'Agostino, T; Davin-Regli, A; Maigre, L; Pagès, JM; Tran, QT; Winterhalter, M | 1 |
Abdala, E; Akova, M; Álvarez, R; Cano, A; Carratalà, J; Cervera, C; Clemente, WT; Freifeld, A; Gómez, L; Gottlieb, T; Gudiol, C; Gurguí, M; Herrera, F; Maestro-de la Calle, G; Manzur, A; Martín-Dávila, P; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Royo-Cebrecos, C; Ruiz-Camps, I; Sukiennik, TC; Tebe, C | 2 |
Barriga, Á; Bravo-Ferrer, J; Delgado, M; Lavín-Alconero, L; López-Cortés, LE; Lupión, C; Núñez-Núñez, M; Retamar, P; Rodríguez-Baño, J; Rosso-Fernández, C | 1 |
Bernabeu, S; Dortet, L; Gonzalez, C; Naas, T | 1 |
Allerberger, F; Jesumirhewe, C; Lepuschitz, S; Ruppitsch, W; Springer, B | 1 |
Ahmad, N; Ali, SM; Khan, AU | 1 |
Klevišar, MN; Lusa, L; Pirš, M; Premru, MM; Strle, F; Stupica, D; Terzić, S | 1 |
Akova, M; Almirante, B; Bonomo, RA; Calbo, E; Carmeli, Y; Daikos, G; Doi, Y; Gasch, O; Giamarellou, H; Gutiérrez-Gutiérrez, B; Harris, PNA; Hernández-Torres, A; Hsueh, PR; Martínez-Martínez, L; Navarro-Francisco, C; Oliver, A; Pascual, Á; Paterson, DL; Peña, C; Pérez, F; Pezzani, MD; Pitout, J; Rodríguez-Baño, J; Ruiz-Garbajosa, P; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Tuon, FF; Venditti, M; Viale, P | 1 |
Brahmi, S; Dunyach-Remy, C; Lavigne, JP; Pantel, A; Sotto, A; Touati, A | 1 |
Deresinski, S; Watkins, RR | 1 |
Darling, LA; Evans, AM; Montero, CI; Nattanmai, SM; Stellrecht, KA | 1 |
Cherian, BP; Ciesielczuk, H; Dolphin, H; Phee, LM; Wareham, DW; Wilks, M | 1 |
Boyer, S; Caron, Y; Chheang, R; Kerléguer, A; Puthea, N; Soda, M; Tarantola, A | 1 |
Barabadi, H; Ramachandran, B; Saravanan, M | 1 |
Mercuro, NJ; Stogsdill, P; Wungwattana, M | 1 |
Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y | 1 |
Hackel, MA; Iaconis, JP; Karlowsky, JA; Sahm, DF | 1 |
Bähr, T; Gatermann, SG; Kohlmann, R | 1 |
Bunk, B; Chakraborty, T; Doijad, SP; Falgenhauer, L; Goesmann, A; Gwozdzinski, K; Hain, T; Hegemann, JD; Imirzalioglu, C; Jaiswal, S; Mannala, GK; Marahiel, MA; Mraheil, MA; Mshana, SE; Overmann, J; Pati, NB; Ryan, D; Schultze, T; Spröer, C; Suar, M; Yao, Y | 1 |
Ansari, M; Munir, T; Saad, N | 1 |
Hackel, MA; Hoban, DJ; Lob, SH; Motyl, MR; Sahm, DF; Young, K | 1 |
Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W | 1 |
Carbonnelle, E; Cattoir, V; Corvec, S; Fihman, V; Garinet, S; Guillard, T; Jacquier, H; Kernéis, S; Le Monnier, A; Morand, PC; Wargnier, A; Woerther, PL; Zahar, JR | 1 |
Achleitner, D; Gatermann, SG; Hartl, R; Kaase, M; Kerschner, H; Lange, F; Pfennigwerth, N | 1 |
Akova, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; de la Calle, C; Falcone, M; Farcomeni, A; Gasch, O; Gozalo, M; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hernández-Torres, A; Hsueh, PR; Karaiskos, I; Lowman, W; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pitout, J; Prim, N; Rodríguez-Baño, J; Rodriguez-Gomez, J; Ruiz-Garbajosa, P; Russo, A; Schwaber, MJ; Souli, M; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, PL | 1 |
Askin, G; Christos, P; Sfeir, MM | 1 |
Guo, Q; Hu, F; Li, Y; Su, J; Wang, M; Wu, S; Xu, S | 1 |
Barbier, F; Burdet, C; Decousser, JW; Lepeule, R; Ruppé, É; Woerther, PL | 1 |
Al-Hasan, MN; Bookstaver, PB; Dash, S; Haggard, E; Justo, JA; Kohn, J; Mediwala, KN; Rac, H; Seddon, MM | 1 |
Harada, R; Kanemitsu, K; Nakamura, K; Nakano, R; Saito, K; Yano, H | 1 |
Haldimann, A; Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N | 1 |
Ambretti, S; Bartoletti, M; Ferraro, G; Furii, F; Giannella, M; Lewis, RE; Pancaldi, L; Pascale, R; Tedeschi, S; Toschi, A; Viale, P | 1 |
Bonomo, RA; Doi, Y; Johnson, JK; Simner, PJ; Tamma, PD | 1 |
Patel, V; Rodriguez, C; Singhal, T; Soman, R; Trivedi, M | 1 |
Cummings, SP; Day, KM; Lanyon, C; Perry, JD; Pike, R; Raza, MW; Winstanley, TG; Woodford, N | 1 |
Castanheira, M; Deshpande, LM; Farrell, SE; Jones, RN; Mendes, RE | 1 |
Bonten, MJ; Cohen Stuart, JW; Dorigo-Zetsma, JW; Frakking, FN; Kluytmans, JA; Leverstein-van Hall, MA; Lutgens, SP; Prins, JM; Rottier, WC; Thijsen, SF; van Hattem, JM; van Hees, BC; Verbon, A; Vlaminckx, BJ | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ | 2 |
Bloemberg, GV; Hombach, M; Mouttet, B | 1 |
Borges, JV; Fonseca, ME; Jaskulski, MR; Machado, DC; Marinowic, DR; Medeiros, BC; Nodari, P; Rocha, MP; Zalewsky, R | 1 |
Amicosante, G; Belhadj, O; Ben Moussa, M; Bourouis, A; Chihi, H; Ferjani, M; Mahrouki, S; Perilli, M | 1 |
Chang, CL; Chang, KK; Huang, YC; Lu, CM; Su, LH; Tai, FT | 1 |
Bojkova, KD; Markovska, RD; Mitov, IG; Stoeva, TJ | 1 |
Bilca, DV; Damjanova, I; Jánvári, L; Lőrinczi, LK; Molnár, S; Székely, E; Tóth, A; Vas, KE | 1 |
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE | 1 |
Jung, JS; Kostrzewa, M; Lange, C; Popp, C; Schubert, S; Sparbier, K | 1 |
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hawser, S; Hoban, D; Morrissey, I | 1 |
Cornaglia, G; Kocsis, E; Lo Cascio, G; Mazzariol, A; Piccoli, M | 1 |
Bonelli, RR; Moreira, BM; Picão, RC | 1 |
Chan, KW; Huang, YC; Kao, CC; Lin, CF; Liu, JW; Liu, PY; Shi, ZY; Shyu, CL; Tung, KC; Wu, ZY | 1 |
Blot, S; Cotta, MO; Lipman, J; Roberts, JA; Tabah, A; Vogelaers, D | 1 |
Alves, M; Bige, N; Canoui, E; Offenstadt, G; Tankovic, J | 1 |
Barth, AL; da Silva, RC; Dalarosa, MG; Falci, DR; Luz, DI; Magagnin, CM; Ribeiro, VB; Rozales, FP; Sampaio, JM; Vieira, FJ; Zavascki, AP | 1 |
Gonzalez-Zorn, B; Ovejero, CM; Pati, BK; Prasad, KN; Rahman, M; Shukla, SK; Singh, A; Srivastava, AK; Tripathi, A | 1 |
Dekhil, M; Djahmi, N; Dunyach-Remy, C; Lavigne, JP; Pantel, A; Sotto, A | 1 |
Angarone, MP; Bolon, MK; Echenique, IA | 1 |
Imwensi, P; Kolář, M; Sedláková, MH; Suchánková, H; Urbánek, K; Vojtová, V | 1 |
Ahn, C; Doi, Y; Hu, F; O'Hara, JA; Rivera, JI; Syed, A | 1 |
Blanchette, LM; Kuti, JL; Nailor, MD; Nicolau, DP | 1 |
Chaubey, VP; Dalton, B; Gregson, DB; Laupland, KB; Pitout, JD; Ross, T | 1 |
Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
Daitch, V; Farbman, L; Lador, A; Leibovici, L; Paul, M; Tredler, Z; Zusman, O | 1 |
Harris, PN; Paterson, DL; Tambyah, PA | 1 |
Chung, HS; Lee, M | 1 |
Gorelik, AL; Karaseva, OV; Katosova, LK; Kryzhanovskaya, OA; Lazareva, AV; Mayanskiy, NA; Ponomarenko, OA | 1 |
Bradford, PA; Eakin, AE; Harris, JJ; Kim, A; McLaughlin, RE; O'Donnell, JP; Patey, S; Singh, R; Tanudra, MA | 1 |
Delgado, M; Pascual, Á; Rodríguez-Baño, J; Torres, E; Valiente, A | 1 |
Brolund, A; Sandegren, L | 1 |
Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K | 1 |
Lee, JH; Lee, JJ; Lee, SH; Park, KS | 1 |
Berkowitz, NM; Campos, J; DeBiasi, RL; Singh, N; Spaeder, MC | 1 |
Carraro, F; Caselli, D; Castagnola, E; Cesaro, S; Colombini, A; Fagioli, F; Meazza, C; Zanazzo, G; Ziino, O | 1 |
Cattoir, V; Giard, JC; Guérin, F; Isnard, C | 1 |
Cuzon, G; Dortet, L; Naas, T; Plésiat, P | 1 |
Cattoir, V; Derdouri, S; Dupont, H; Emond, JP; Gaillard, N; Gaillot, O; Girard de Courtilles, M; Goetgheluck, AS; Lecuru, M; Lemaire, B; Mammeri, H; Plassart, C | 1 |
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Fattouh, R; McGeer, A; Melano, RG; Patel, SN; Poutanen, SM; Tijet, N | 1 |
Doi, Y; McElheny, CL; Snyder, JW; Thomson, GK; Thomson, KS | 1 |
Heil, EL; Johnson, JK | 1 |
Bork, JT; D'Angelo, RG; Heil, EL; Johnson, JK | 1 |
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P | 1 |
Aberkane, S; Bouzinbi, N; Carriere, C; Decré, D; Godreuil, S; Jean-Pierre, H; Kissou, A; Nacro, B; Ouédraogo, AS; Ouédraogo, R; Poda, A; Sanou, S; Van De Perre, P | 1 |
Chung, HS; Lee, M; Yong, D | 1 |
Cao, XL; Cheng, L; Ning, MZ; Shen, H; Zhang, K; Zhang, ZF; Zhou, WQ | 1 |
Davis, SL; Grunwald, JL; Kenney, RM; Veve, MP; Wagner, JL | 1 |
Burgers, PC; Dekker, LJ; Goessens, WH; Kostzrewa, M; Luider, TM; Monteferrante, CG; Peer, M; Sparbier, K; Sultan, S; Ten Kate, MT | 1 |
Borgia, G; Gentile, I; Maraolo, AE | 1 |
Hsueh, PR; Jean, SS | 1 |
Al-Hasan, MN; Albrecht, H; Bookstaver, PB; Hammer, KL; Justo, JA; Kohn, J | 1 |
Gales, AC; Sampaio, JL | 1 |
Aissa, N; Beyrouthy, R; Bonacorsi, S; Bonnet, R; Bret, L; Brieu, N; Cattoir, V; Chapuis, A; Chardon, H; Colomb-Cotinat, M; Degand, N; Doucet-Populaire, F; Dubois, V; Fortineau, N; Grillon, A; Lanotte, P; Leyssene, D; Patry, I; Ploy, MC; Podglajen, I; Ponties, V; Recule, C; Robin, F; Ros, A | 1 |
Al-Hasan, MN; Albrecht, H; Augustine, MR; Bookstaver, PB; Justo, JA; Kohn, J; Testerman, TL | 1 |
Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Seifert, H; Tacconelli, E; Willmann, M | 1 |
Jitmuang, A; Kiratisin, P; Rattanaumpawan, P; Thamlikitkul, V; Werarak, P | 1 |
Aslanzadeh, J; Kuti, JL; Nicolau, DP; Stainton, SM; Thabit, AK | 1 |
Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N | 1 |
Chuang, YC; Ku, YH; Yu, WL | 1 |
Pitout, JD | 1 |
Pascual, A; Rodríguez-Baño, J | 1 |
Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK | 1 |
Clifton-Hadley, F; Coldham, NG; Kirchner, M; Liebana, E; Randall, LP; Teale, CJ | 1 |
Harada, S; Ishii, Y; Yamaguchi, K | 1 |
Jacoby, GA | 1 |
Derbyshire, H; Evans, K; Kavuri, U; Kay, G; Vaughan, C; Winstanley, T | 1 |
Amicosante, G; Celenza, G; Forcella, C; Frascaria, P; Pellegrini, C; Perilli, M; Segatore, B | 1 |
Ashcroft, M; Weinbren, M | 1 |
Corso, A; Guerriero, L; Mendez, T; Pasteran, F; Rapoport, M | 1 |
Dove, MG; Ehlers, MM; Hoosen, AA; Kock, MM; Makgotlho, EP; Veldsman, C | 1 |
Church, DL; Gregson, DB; Le, PG; Moore, KL; Pitout, JD | 1 |
Bernabeu, S; Monnet, X; Nordmann, P; Poirel, L; Potron, A; Richard, C | 1 |
Behera, B; Das, A; Kapil, A; Mathur, P | 1 |
Andreacchio, K; Edelstein, PH; Hu, B; McGettigan, SE; Nachamkin, I | 1 |
Falagas, ME; Karageorgopoulos, DE | 1 |
Darini, AL; Minarini, LA; Nordmann, P; Poirel, L; Trevisani, NA | 1 |
Fatima, N; Malik, A; Rashid, M; Rizvi, M; Shukla, I; Siddiqui, S; Usman, A | 2 |
Ayala, J; Di Conza, J; Gutkind, G; Porto, A | 1 |
Fulcher, LC; Jorgensen, JH; McElmeel, ML; Zimmer, BL | 1 |
Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F | 1 |
Bochum, ET; Handgraaf, C; Klaassen, T; Melchers, WJ; Sturm, PD; van Mook-Vermulst, SV | 1 |
Arlet, G; Da Costa, A; Dallenne, C; Decré, D; Favier, C | 1 |
Bennett, JW; Herrera, ML; Jorgensen, JH; Lewis, JS; Mende, K; Murray, CK; Wickes, BL; Yu, X | 1 |
Ferreira, S; Mendo, S; Paradela, A; Ramalheira, E; Velez, J; Walsh, TR | 1 |
Cocquerelle, V; Jaulhac, B; Jehl, F; Lefèvre, S; Riegel, P; Scheftel, JM | 1 |
Du, X; Ji, S; Li, L; Qi, Y; Shen, P; Wei, Z; Yu, Y | 1 |
Petropoulou, D; Poulou, A; Pournaras, S; Sofianou, D; Themeli-Digalaki, K; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
Alepopoulou, E; Grapsa, A; Ikonomidis, A; Kartali-Ktenidou, S; Panopoulou, M; Paspalidou, E | 1 |
Hanberger, H; Johansson, AV; Monstein, HJ; Nilsson, LE; Nilsson, M; Ostholm-Balkhed, A; Tärnberg, M | 1 |
Abe, N; Akagi, M; Fukuda, S; Higuchi, T; Hirai, I; Jikimoto, T; Kida, K; Kinoshita, S; Kofuku, T; Komatsu, M; Miyamoto, K; Miyamoto, Y; Nakai, I; Nishi, I; Nishio, H; Ono, T; Orita, T; Sakamoto, M; Satoh, K; Sueyoshi, N; Toyokawa, M; Wada, Y; Yamamoto, Y; Yamasaki, K | 1 |
Araj, GF; Corkill, JE; Harajly, M; Khairallah, MT; Matar, GM | 1 |
Salman, S; Van Sickels, JE; Young, M | 1 |
Ferraro, MJ; Hooper, DC; Hyle, EP; Lee, H; Silver, M | 1 |
Carrër, A; Nordmann, P; Poirel, L; Toleman, MA; Walsh, TR | 1 |
Bolognesi, MP; Henderson, RA; Kaufman, AM; Watters, TS; Wellman, SS | 1 |
Drieux-Rouzet, L; Garrec, H; Golmard, JL; Jarlier, V; Robert, J | 1 |
Hsu, MS; Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Yang, CJ | 1 |
Bayraktar, B; Dalgic, N; Dincer, E; Pelit, S; Sancar, M | 1 |
Agın, H; Devrim, I; Dizdarer, C; Gulfidan, G; Gunay, I; Güven, B; Yılmazer, MM | 1 |
Berthelot, P; Carrër, A; Carricajo, A; Fortineau, N; Nordmann, P; Poirel, L; Ros, A | 1 |
Ishii, Y; Kouyama, Y; Tateda, K; Ueda, C; Yamaguchi, K | 1 |
Dihmess, A; Evans, A; Fiorenza, M; Graffunder, E; Harrington, S; Lodise, TP; Martis, P; Masoud, R; McNutt, LA; Patel, N; Woo, B | 1 |
Fujita, N; Satake, S; Shime, N | 1 |
Curran, MD; Ludlam, HA; Shet, VG; Swayne, RL; Woodford, N | 1 |
Al Naiemi, N; Arents, N; Diederen, B; Fluit, A; Leverstein-van Hall, M; Mouton, JW; Stuart, JC; Thijsen, S; Vlaminckx, B | 1 |
Koh, TH; Krishnan, P; Ong, DC; Syahidah, N; Tan, TY | 1 |
Bhattacharjee, A; Ranjan Sen, M; Seema, K; Upadhyay, S | 1 |
Agodi, A; Koumaki, V; Poulou, A; Pournaras, S; Sofianou, D; Themeli-Digalaki, K; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
Andremont, A; Chau, F; de Lastours, V; Fantin, B; Lucet, JC; Pasquet, B; Pitsch, A; Ruppé, E; Tubach, F | 1 |
Badal, R; Bonomo, RA; Bouchillon, S; Hackel, M; Hoban, D; Hujer, AM; Lascols, C; Marshall, SH | 1 |
Algorta, G; Ayala, JA; Bado, I; Cordeiro, NF; García-Fulgueiras, V; Gutkind, G; Mota, MI; Robino, L; Varela, A; Vignoli, R | 1 |
Chen, CP; Chen, TL; Fung, CP; Lee, YT; Siu, LK | 1 |
Khan, HM; Malik, A; Rashid, M; Shahid, M; Shukla, I; Singh, A; Sobia, F | 1 |
Beekmann, SE; Kallen, AJ; Lentnek, AL; Limbago, B; Patel, J; Polgreen, PM; Srinivasan, A | 1 |
Baraniak, A; Bojarska, K; Fiett, J; Gniadkowski, M; Grabowska, A; Herda, M; Hryniewicz, W; Izdebski, R; Kania-Pudło, M; Młynarczyk, G; Żabicka, D; Żak-Puławska, Z | 1 |
Amicosante, G; Celenza, G; Luzzaro, F; Mugnaioli, C; Perilli, M; Pini, B; Rossolini, GM; Segatore, B; Stefani, S | 1 |
Bloemberg, GV; Giger, J; Hombach, M; Meyer, V; Polsfuss, S | 1 |
Khan, AU; Nordmann, P | 1 |
Brink, AJ; Clay, CG; Coetzee, J; Nordmann, P; Poirel, L; Richards, GA; Sithole, S | 1 |
Hung, KH; Wu, JJ; Yan, JJ; Yang, FC | 1 |
Caniça, M; Diogo, J; Ferreira, E; Jones-Dias, D; Louro, D; Manageiro, V; Pinto, M | 1 |
Bourigault, C; Caroff, N; Corvec, S; Crémet, L; Guillouzouic, A; Juvin, ME; Lepelletier, D; Reynaud, A | 1 |
Ahmad, J; Malik, A; Zubair, M | 1 |
Bloemberg, GV; Böttger, EC; Giger, J; Hombach, M; Meyer, V; Polsfuss, S | 1 |
Arlet, G; Philippon, A | 1 |
Abreu-Lanfranco, O; Bhargava, P; Bheemreddy, S; Blunden, C; Carmeli, Y; Chopra, T; Chugh, N; Collins, VL; Eiseler, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Memon, BI; Moshos, J; Munoz-Price, LS; Pogue, JM; Shallal, A; Sunkara, B | 1 |
Cheng, NC; Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Teng, LJ | 1 |
Cheng, VC; Chiu, SS; Ho, PL; Lai, EL; Li, Z | 1 |
Dong, N; Liu, W; Zhang, XH | 1 |
Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J | 1 |
Giske, CG; Gniadkowski, M; Miriagou, V; Nordmann, P; Poirel, L; Woodford, N | 1 |
Balakrishnan, I; Halstead, FD; Vanstone, GL | 1 |
Amicosante, G; Belhadj, O; Celenza, G; Chihi, H; Mahrouki, S; Mohamed, BM; Perilli, M | 1 |
Bitterman, H; Denekamp, Y; Kochavi, T; Vardi, M | 1 |
Hsueh, PR | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Ho, MW; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
Chanawong, A; Charoensri, N; Chetchotisakd, P; Kerdsin, A; Lulitanond, A; Phumsrikaew, W; Rimrang, B; Sribenjalux, P; Wilailuckana, C; Wonglakorn, L | 1 |
Autenrieth, IB; Gröbner, S; Marschal, M; Pfeifer, Y; Weissgerber, P; Wienke, M | 1 |
Brhelova, E; Cizek, A; Dobiasova, H; Dolejska, M; Dubska, L; Jurankova, J; Krivdova, J; Kutnikova, L; Literak, I; Sevcikova, A; Sterba, J; Vavrina, M | 1 |
Cartuyvels, R; Magerman, K; Raymaekers, M; Verhaegen, J; Willems, E | 1 |
Koh, TH; Krishnan, PU; Lim, TP; Lye, D; Marimuthu, K; Ng, TM; Tan, TY; Teng, C | 1 |
Cartuyvels, R; Magerman, K; Nys, S; Verhaegen, J; Willems, E | 1 |
Bartizal, K; Friedland, I; Motyl, M; Pelak, BA; Teppler, H; Woods, GL | 1 |
Ahmed, S; Hameed, A; Hasan, F; Shah, AA | 2 |
Berthel, M; Heitz, D; Jehl, F; Kaltenbach, G; Kiesmann, M; Kuntzmann, F; Martin-Hunyadi, C; Noblet-Dick, M; Vogel, T | 1 |
Wang, F; Xiong, Z; Zhang, Y; Zhu, D | 1 |
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL | 1 |
An, YJ; Choi, YW; Jeong, SH; Jung, HI; Jung, YC; Kim, JY; Lee, KJ; Lee, SH; Shin, SH; Sohn, ES | 1 |
Conceição, T; Duarte, A; Faria, N; Lito, L; Melo Cristino, J; Salgado, MJ | 1 |
Hawkey, PM; Li, C; Munday, CJ; Shen, D; Xiong, J | 1 |
Alhambra, A; Alós, JI; Cacho, J; Cuadros, JA; Gómez-Garcés, JL | 1 |
Agnifili, A; Amicosante, G; Franceschini, N; Franchino, L; Perilli, M; Rossolini, GM; Segatore, B; Setacci, D | 1 |
Ferguson, EC; Matthias, KR; Nix, DE | 1 |
Datta, P; Gupta, V; Mishra, B; Thakur, A | 1 |
Baquero, F; Cantón, R; Coque, TM; Rollán, A; Sánchez-Moreno, MP; Valverde, A | 1 |
Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J | 1 |
Han, L; Jiang, X; Jiang, Y; Li, M; Liu, H; Lu, Y; Ni, Y; Yang, L; Yuan, F | 1 |
Chryssouli, Z; Galani, I; Giamarellou, H; Orlandou, K; Souli, M | 1 |
Carmeli, Y; Navon-Venezia, S; Schwaber, MJ; Schwartz, D | 1 |
Chen, M; Jones, RN; Pottumarthy, S; Sader, HS; Yu, Y | 1 |
Fortineau, N; Lartigue, MF; Nordmann, P | 1 |
Bujdáková, H; Duez, JM; Labia, R; Neuwirth, C; Péchinot, A; Siebor, E; Zarnayová, M | 1 |
Daoud, Z; Doucet-Populaire, F; Hakimé, NI; Hamzé, M; Mangeney, N; Matta, H; Mokhbat, JE; Moubareck, C; Rohban, R; Sarkis, DK | 1 |
Turner, PJ | 1 |
Ambrose, PG; Craig, WA; Dudley, MN; Jones, RN; Pottumarthy, S | 1 |
Dolna, I; Franiczek, R; Krzyzanowska, B; Mokracka, G; Szufnarowski, K | 1 |
Burgess, DS; Frei, CR | 1 |
Arpin, C; Brochet, JP; Dubois, V; Dutilh, B; Fischer, I; Jullin, J; Larribet, G; Maugein, J; Quentin, C | 1 |
Bonomo, RA; Paterson, DL | 1 |
Chuang, YM; Ho, YC; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
Hansen, DS | 1 |
Bezuidenhout, S; Jankowits, CE; Moolman, GJ; Pitout, JD | 1 |
Baquero, F; Cantón, R; Coque, TM; García-Castillo, M; Loza, E; Morosini, MI; Novais, A; Valverde, A | 1 |
Chuang, YC; Walther-Rasmussen, J; Yu, WL | 1 |
Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV | 1 |
Birkett, CI; Brown, DFJ; Brown, NM; Curran, MD; Ludlam, HA; Milner, N; Roberts, MTM; Woodford, N | 1 |
Jacobs, E; Schmidt, H; Schmitt, J | 1 |
Mammeri, H; Nordmann, P | 1 |
Amicosante, G; Celenza, G; Fiore, M; Luzzaro, F; Pellegrini, C; Perilli, M; Rossolini, GM; Segatore, B | 1 |
Allouch, PY; Breton, N; Decousser, JW; Galas, M; Godard, T; Pina, P | 1 |
Benallaoua, S; Brasme, L; De Champs, C; Gharout, A; Madoux, J; Touati, A | 1 |
Nieradko, J | 1 |
Alos, JI; Cacho, J; Cuadros, J; Gomez-Garces, JL; Orden, B; Tamayo, J | 1 |
Cornaglia, G; Garau, J; Livermore, DM | 1 |
Hawkey, PM | 1 |
MacGowan, A | 1 |
Giamarellou, H | 1 |
Balbinot, A; Catavitello, C; D'Antonio, D; Di Berardino, F; Di Bonaventura, G; Di Zacomo, S; Esattore, F; Favaro, M; Febbo, F; Fontana, C; Manna, A; Pompetti, F; Savini, V; Talia, M | 1 |
Ammari, H; Arlet, G; Bakour, R; Iabadene, H; Lounes, S; Messai, Y; Ramdani-Bouguessa, N | 1 |
Berçot, B; Fihman, V; Jacquier, H; Lartigue, MF; Meunier, F; Raskine, L; Riahi, J; Sanson-le Pors, MJ; Schnepf, N | 1 |
Baraniak, A; Empel, J; Fiett, J; Gniadkowski, M; Hryniewicz, W; Literacka, E; Mrówka, A; Sadowy, E | 1 |
Katona, K; Kocsis, B; Kristóf, K; Nagy, K; Rókusz, L; Szabó, D; Szentandrássy, J | 1 |
Chang, HH; Chung, DR; Jung, DS; Jung, SI; Ki, HK; Kim, SW; Kim, YS; Ko, KS; Kwon, KT; Lee, H; Lee, MY; Lee, NY; Peck, KR; Song, JH; Yeom, JS | 1 |
Bauernfeind, A; Dragijeva, E; Hadjieva, N; Haydouchka, I; Ivanova, D; Keuleyan, E; Lazarova, G; Markova, B; Markovska, R; Mitov, I; Savov, E; Schneider, I; Setchanova, L; Sredkova, M | 1 |
Ball, AP; Brookes, GR; Davey, PG; Farrell, ID; Geddes, AM | 1 |
Verbist, L | 1 |
Neu, HC | 2 |
Haneberg, B; Solberg, CO | 1 |
Kabins, SA; Nathan, C; Olson, B; Weinstein, RA | 1 |
Ehrhardt, AF; Sanders, CC | 1 |
Prevan, AM; Sanders, CC; Thomson, KS | 1 |
Jones, RN | 1 |
Bollet, C; Bornet, C; Chevalier, J; Davin-Regli, A; Eyraud, A; Mallea, M; Pages, JM | 1 |
Carriere, C; Darbas, H; Marchandin, H; Pierre, HJ; Sirot, D | 1 |
Giakkoupi, P; Kemeroglou, A; Loukova, V; Sofianou, D; Tsakris, A; Tzelepi, E | 1 |
Allerberger, F; Bagová, M; Bujdáková, H; Dierich, MP; Hanzen, J; Kettner, M; Klimáková, J; Michálková-Papajová, D; Moravcíková, M | 1 |
Fennewald, M; Girlich, D; Karim, A; Leelaporn, A; Nordmann, P; Poirel, L; Tribuddharat, C | 1 |
Duez, JM; Garel, F; Kazmierczak, A; Labia, R; Neuwirth, C; Pechinot, A; Pruneaux, M; Siebor, E | 1 |
Rahal, JJ | 1 |
Choi, EH; Hong, JY; Jacoby, GA; Lee, HJ; Pai, H | 1 |
Bujdáková, H; Hanzen, J; Jakab, A; Jankovicová, S; Kallová, J; Kettner, M; Klimácková, J; Michálková-Papajová, D; Milosovic, P; Moravcíková, M | 1 |
Baquero, F; Cantón, R; Coque, TM; Oliver, A; Pérez-Díaz, JC; Varela, Mdel C | 1 |
Arpin, C; Dubois, V; Labia, R; Noury, P; Quentin, C; Souquet, M | 1 |
Avril, JL; Cattoen, C; Chardon, H; Croix, JC; Dabernat, H; Dib, C; Fosse, T; Ghnassia, JC; Lecaillon, E; Marmonier, A; Moniot-Ville, N; Nicolas-Chanoine, MH; Rezvani, Y; Roussel-Delvallez, M; Sirot, J; Soussy, CJ; Trevoux, A; Vandenesch, F | 1 |
Steffee, CH; Wasilauskas, BL | 1 |
Mansa, B; Nir, M; Schumacher, H; Thomsen, VF | 1 |
Ben Hassen, A; Ben Redjeb, S; Chourou, O; Fendri, C; Kammoun, A | 1 |
Anene, CA; Bittner, MJ; Mellencamp, MA; Preheim, LC; Roccaforte, JS; Sanders, CC | 1 |
Craig, WA; Ebert, S; Fantin, B; Leggett, JE | 1 |
Almdahl, SM; Andersen, BM; George, R; Gilfillian, A; Hotvedt, R; Olafsen, K; Sørlie, D | 1 |
Michéa-Hamzehpour, M; Pechère, JC | 1 |
Buré, A; Frottier, J; Legrand, P; Perronne, C; Régnier, B; Vachon, F; Vildé, JL | 1 |
Sanders, CC; Sanders, WE | 1 |
41 review(s) available for beta-lactams and Cronobacter Infections
Article | Year |
---|---|
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Randomized Controlled Trials as Topic; Sepsis | 2023 |
Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2020 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Severity of Illness Index | 2021 |
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda.
Topics: Anti-Bacterial Agents; beta-Lactams; Blood Culture; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Observational Studies as Topic; Quality Indicators, Health Care; Randomized Controlled Trials as Topic; Sepsis | 2021 |
The prevalence and drug resistance pattern of extended spectrum β-lactamases (ESBLs) producing Enterobacteriaceae in Africa.
Topics: Africa; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2018 |
Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Observational Studies as Topic; Survival Analysis; Treatment Outcome; Young Adult | 2018 |
Carbapenems and alternative β-lactams for the treatment of infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: What impact on intestinal colonisation resistance?
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Disease Models, Animal; Enterobacteriaceae; Enterobacteriaceae Infections; Gastrointestinal Microbiome; Humans | 2018 |
A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2019 |
Antimicrobial resistance among Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Food Microbiology; Gene Expression; Humans; Political Systems; Socioeconomic Factors; South America | 2014 |
Antimicrobial stewardship of β-lactams in intensive care units.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Critical Illness; Drug Dosage Calculations; Enterobacteriaceae; Enterobacteriaceae Infections; Guidelines as Topic; Humans; Intensive Care Units; Microbial Sensitivity Tests; Precision Medicine | 2014 |
Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries.
Topics: Acinetobacter baumannii; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Mediterranean Region; Plasmids | 2014 |
β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Treatment Outcome | 2015 |
Impact of borderline minimum inhibitory concentration on the outcome of invasive infections caused by Enterobacteriaceae treated with β-lactams: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2015 |
Characterization of ESBL disseminating plasmids.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids | 2016 |
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Plasmids; Polymyxins | 2016 |
Multiresistant Enterobacteriaceae: new threat of an old problem.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Plasmids | 2008 |
Clinical significance of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors | 2008 |
Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests | 2008 |
AmpC beta-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Plasmids | 2009 |
Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; South Africa | 2009 |
Extended-spectrum beta-lactamase-producing organisms.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2009 |
How to detect NDM-1 producers.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2011 |
[Enterobacteriaceae and beta-lactams : wild susceptibility patterns].
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Phenotype; Phylogeny | 2012 |
Identification and screening of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carrier State; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Mass Screening; Microbial Sensitivity Tests | 2012 |
Towards a phenotypic screening strategy for emerging β-lactamases in Gram-negative bacilli.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2013 |
Extended-spectrum beta-lactamases (ESbLs): characterization, epidemiology and detection.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2004 |
Extended-spectrum beta-lactamases.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Incidence | 2005 |
Extended-spectrum beta-lactamases: a clinical update.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Microbial Sensitivity Tests; Plasmids | 2005 |
Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
Topics: beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Epidemiology; Taiwan | 2006 |
Extended-spectrum cephalosporinases: structure, detection and epidemiology.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporinase; Enterobacteriaceae; Enterobacteriaceae Infections; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Secondary | 2007 |
Prevalence and clonality of extended-spectrum beta-lactamases in Asia.
Topics: Asia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Integrons | 2008 |
Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Monte Carlo Method | 2008 |
beta-Lactams without a suicide inhibitor.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 2008 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
beta-Lactam resistance amongst Enterobacter species.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans | 1993 |
Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 1996 |
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans | 1998 |
Extended-spectrum beta-lactamases: how big is the problem?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Risk Factors | 2000 |
Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans; Microbial Sensitivity Tests; Mutation; Porins | 1985 |
7 trial(s) available for beta-lactams and Cronobacter Infections
Article | Year |
---|---|
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Administration Routes; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Research Design; Treatment Outcome | 2017 |
Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams.
Topics: Administration, Oral; Aged; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome | 2016 |
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2017 |
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2003 |
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities | 2006 |
Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
Topics: Administration, Oral; Amoxicillin; Bacteriuria; beta-Lactamase Inhibitors; beta-Lactams; Biological Products; Carboxylic Acids; Clavulanic Acid; Clinical Trials as Topic; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Streptomyces; Tablets; Urinary Tract Infections | 1980 |
241 other study(ies) available for beta-lactams and Cronobacter Infections
Article | Year |
---|---|
High level of intrinsic phenotypic antimicrobial resistance in enterobacteria from terrestrial wildlife in Gabonese national parks.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Feces; Gabon; Gorilla gorilla; Mandrillus; Microbial Sensitivity Tests; Parks, Recreational; Phenotype; Prevalence | 2021 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |
Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Lactams; Retrospective Studies; Urinary Tract Infections | 2023 |
Development of a prediction model for the acquisition of extended spectrum beta-lactam-resistant organisms in U.S. international travellers.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prospective Studies; Risk Factors | 2023 |
Epidemiology and risk factors for carbapenemase-producing Enterobacteriaceae carriage in the hospital: A population-based nested case-control study.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Risk Factors | 2023 |
Draft genome sequencing and annotation of a low-virulence Morganella morganii strain CQ-M7, a multidrug-resistant isolate from the giant salamander in China.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Genome Size; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Kidney; Microbial Sensitivity Tests; Molecular Sequence Annotation; Morganella morganii; Urodela; Virulence; Whole Genome Sequencing | 2020 |
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests | 2020 |
Differential DNA accessibility to polymerase enables 30-minute phenotypic β-lactam antibiotic susceptibility testing of carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; DNA-Directed DNA Polymerase; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Microbial Sensitivity Tests; Phenotype; Reproducibility of Results; Time Factors | 2020 |
Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms.
Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Philadelphia; Retrospective Studies | 2020 |
Use of Monte Carlo simulation to optimize antibiotic selection for bloodstream infections caused by Enterobacteriaceae in Shandong Province, China.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; China; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Monte Carlo Method | 2020 |
Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Cohort Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2020 |
High carriage of ESBL-producing Enterobacteriaceae associated with sexual activity among men who have sex with men.
Topics: Adult; Anal Canal; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Carrier State; Cohort Studies; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; HIV Infections; Homosexuality, Male; Humans; Male; Middle Aged; Netherlands; Prevalence; Risk Factors; Sexual and Gender Minorities; Sexual Behavior | 2021 |
Transmission Dynamics of Antimicrobial Resistance at a National Referral Hospital in Uganda.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carrier State; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Hospitals; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Referral and Consultation; Uganda | 2021 |
Comparison of outcomes in urinary tract infections caused by AmpC-harboring organisms treated with AmpC stable versus AmpC susceptible agents.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections | 2021 |
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline | 2017 |
Porin flexibility in Providencia stuartii: cell-surface-exposed loops L5 and L7 are markers of Providencia porin OmpPst1.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Enterobacteriaceae Infections; Genetic Variation; Humans; Microbial Sensitivity Tests; Porins; Providencia; Sequence Alignment | 2017 |
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia | 2017 |
Comparison of Two Phenotypic Algorithms To Detect Carbapenemase-Producing Enterobacteriaceae.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Clavulanic Acids; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Humans; Imipenem; Penicillins; Ticarcillin | 2017 |
Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Cefotaxime; Ceftazidime; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Ertapenem; Fluoroquinolones; Humans; Nigeria; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
Detection of New Delhi Metallo-β-Lactamase Variants NDM-4, NDM-5, and NDM-7 in Enterobacter aerogenes Isolated from a Neonatal Intensive Care Unit of a North India Hospital: A First Report.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Bleomycin; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; India; Infant, Newborn; Intensive Care Units, Neonatal; Isoenzymes; Male; Plasmids; Tertiary Care Centers | 2018 |
Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Male; Retrospective Studies; Urinary Tract Infections | 2017 |
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Global Health; Humans; Male; Middle Aged; Retrospective Studies; Sepsis | 2017 |
High Prevalence of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Wild Fish from the Mediterranean Sea in Algeria.
Topics: Algeria; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Fish Diseases; Fishes; Fluoroquinolones; Gastrointestinal Tract; Gene Expression; Genotype; Gills; Klebsiella pneumoniae; Mediterranean Sea; Microbial Sensitivity Tests; Phylogeny; Plasmids; Prevalence | 2018 |
Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2017 |
A Triple-Disk Enrichment Method for Carbapenem-Resistant Enterobacteriaceae (CRE) Screening.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fluconazole; Humans; Linezolid; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2017 |
Optimal detection of carbapenemase-producing Enterobacteriaceae from rectal samples: a role for enrichment?
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Mass Screening; Microbial Sensitivity Tests; Rectum; Retrospective Studies | 2018 |
Beta-lactam resistance among Enterobacteriaceae in Cambodia: The four-year itch.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cambodia; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2018 |
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
Analysis of Potential β-Lactam Surrogates To Predict
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Ceftazidime; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2018 |
Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Chromosomes, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Mutation Rate; Species Specificity | 2018 |
Enterobacter bugandensis: a novel enterobacterial species associated with severe clinical infection.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cytokines; Disease Models, Animal; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Genome, Bacterial; Humans; Mice; O Antigens; Plasmids; Survival Rate; Transcriptome; Virulence | 2018 |
Phenotypic Identification, Frequency Distribution and Antibiogram of Carbapenemase Producing Enterobacteriaceae in Clinical Isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity | 2018 |
Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans | 2018 |
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Elective distribution of resistance to beta-lactams among Enterobacter cloacae genetic clusters.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporinase; Chaperonin 60; Child; Child, Preschool; Enterobacter cloacae; Enterobacteriaceae Infections; Female; France; Genotype; Hospitals, University; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prospective Studies; Sequence Analysis, DNA; Young Adult | 2018 |
LMB-1, a novel family of class B3 MBLs from an isolate of Enterobacter cloacae.
Topics: Anti-Bacterial Agents; Austria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; Recombinant Proteins; Sequence Homology; Whole Genome Sequencing | 2018 |
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Decision Support Techniques; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome | 2018 |
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Case-Control Studies; Cefoperazone; China; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam | 2018 |
Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; South Carolina; Time Factors | 2019 |
Indication of Minimum Inhibitory Concentration of β-Lactam Antimicrobials for the Primary Extraction of IMP-Producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Inosine Monophosphate; Microbial Sensitivity Tests | 2019 |
Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Microbial Sensitivity Tests; Prospective Studies; United Kingdom | 2019 |
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Enterobacteriaceae Infections; Female; Humans; Incidence; Italy; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Failure; Young Adult | 2019 |
The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tertiary Healthcare; Treatment Outcome | 2012 |
Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; United Kingdom | 2013 |
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).
Topics: Bacteremia; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; United States | 2013 |
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Comorbidity; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2013 |
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections | 2013 |
Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Practice Guidelines as Topic | 2013 |
Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Porins | 2013 |
Prevalence of quinolone resistance determinant qnrA6 among broad- and extended-spectrum beta-lactam-resistant Proteus mirabilis and Morganella morganii clinical isolates with sul1-type class 1 integron association in a Tunisian Hospital.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Female; Genes, Bacterial; Hospitals, Military; Humans; Integrons; Male; Middle Aged; Molecular Typing; Morganella morganii; Plasmids; Polymerase Chain Reaction; Proteus mirabilis; Quinolones; Sequence Analysis, DNA; Tunisia | 2013 |
Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Disinfection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genes, Bacterial; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan; Ureteroscopes; Urinary Tract Infections | 2013 |
Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Bulgaria; Child; Conjugation, Genetic; Enterobacter; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Pantoea; Plasmids; Serratia Infections; Serratia marcescens | 2014 |
First description of bla(NDM-1), bla(OXA-48), bla(OXA-181) producing Enterobacteriaceae strains in Romania.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Romania | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 2014 |
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures.
Topics: Bacteremia; beta-Lactam Resistance; beta-Lactams; Blood; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; beta-Lactams; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Predictive Value of Tests; Proteus mirabilis; Sensitivity and Specificity | 2014 |
KPC-3 carbapenemase harbored in FIIk plasmid from Klebsiella pneumoniae ST512 and Escherichia coli ST43 in the same patient.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Bile; Colistin; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Plasmids; Tigecycline | 2014 |
Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests | 2014 |
Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Substrate Specificity | 2014 |
Heteroresistance to carbapenems in New Delhi metallo-β-lactamase-1-producing isolates: a challenge for detection?
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disease Susceptibility; Drug Resistance, Multiple; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Providencia; Thienamycins | 2014 |
Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child, Preschool; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Expression Regulation, Bacterial; Humans; India; Isoenzymes; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Survival Analysis; Tertiary Care Centers | 2014 |
A bridge too far.
Topics: beta-Lactamases; beta-Lactams; End Stage Liver Disease; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Liver Transplantation; Male; Preoperative Period | 2014 |
Antibiotic consumption and its influence on the resistance in Enterobacteriaceae.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Linear Models; Microbial Sensitivity Tests; Proteus mirabilis | 2014 |
Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Pennsylvania; Plasmids; Young Adult | 2014 |
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2014 |
Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.
Topics: Adult; Aged; Alberta; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Population Surveillance | 2014 |
Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Taiwan; Thienamycins | 2015 |
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hypoalbuminemia; Israel; Middle Aged; Prospective Studies; Risk Factors | 2015 |
Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals, University; Humans; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity; Tertiary Care Centers | 2015 |
[Monitoring and antibiotic resistance profile of tracheal aspirate microbiota in ICU children with severe craniocerebral trauma].
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Child; Colistin; Craniocerebral Trauma; Cross Infection; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Expression; Humans; Intensive Care Units, Pediatric; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Trachea; Trauma Severity Indices | 2014 |
Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactams; Disease Models, Animal; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Mice; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome | 2015 |
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins | 2015 |
Urgent need for β-lactam-β-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans | 2015 |
Empiric Monotherapy Versus Combination Therapy for Enterobacteriaceae Bacteremia in Children.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Retrospective Studies | 2015 |
Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy.
Topics: Adolescent; Antineoplastic Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Infant; Infant, Newborn; Italy; Male; Neoplasms; Prospective Studies; Retrospective Studies; Survival Analysis | 2016 |
Complex Regulation Pathways of AmpC-Mediated β-Lactam Resistance in Enterobacter cloacae Complex.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Deletion; Gene Knockout Techniques; Humans; Microbial Sensitivity Tests; Mutation; Plasmids; Transcriptome | 2015 |
Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Mass Screening; Prospective Studies | 2016 |
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Ceftazidime; Dipeptides; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; France; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence; Prospective Studies | 2016 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacter; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella; Meropenem; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Thienamycins | 2015 |
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor Combinations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Order; Genetic Loci; Humans; Microbial Sensitivity Tests | 2016 |
Impact of CLSI Breakpoint Changes on Microbiology Laboratories and Antimicrobial Stewardship Programs.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Therapy; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2016 |
Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Burkina Faso; Case-Control Studies; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Gene Expression; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Multiplex Polymerase Chain Reaction; Phylogeny | 2017 |
Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital.
Topics: Aged; Aged, 80 and over; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitals, University; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Tertiary Care Centers | 2016 |
Survey of Clinical Extended-Spectrum Beta-Lactamase-Producing Enterobacter cloacae Isolates in a Chinese Tertiary Hospital, 2012-2014.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Integrons; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Public Health Surveillance; Tertiary Care Centers | 2017 |
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Male; Middle Aged; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clinical Laboratory Techniques; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections | 2016 |
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Tr
Topics: Anti-Bacterial Agents; Asia; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Pacific Islands; Urinary Tract Infections | 2017 |
Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment | 2017 |
Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Clone Cells; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Gene Expression; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Prevalence; Replicon | 2017 |
Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Assessment; Risk Factors; South Carolina | 2017 |
In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Cephalosporins; Colistin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Hospitalization; Humans; Klebsiella; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tetracycline; Tigecycline | 2017 |
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospectiv
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Superinfection | 2017 |
Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Connecticut; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation | 2008 |
In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Serratia marcescens; Taiwan; Tigecycline | 2008 |
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests | 2009 |
Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Sensitivity and Specificity | 2009 |
A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Order; Genes, Bacterial; Hospitals, Teaching; Humans; Italy; Urinary Tract Infections | 2009 |
Ertapenem resistance and the Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem | 2009 |
Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Clinical Laboratory Techniques; Diagnostic Errors; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Mass Screening; Microbial Sensitivity Tests; Sensitivity and Specificity | 2009 |
Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Proteus mirabilis; Sensitivity and Specificity | 2010 |
Nosocomial spread of ESBL-positive Enterobacter cloacae co-expressing plasmid-mediated quinolone resistance Qnr determinants in one hospital in France.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; France; Genes, Bacterial; Hospitals; Humans; Plasmids; Quinolones | 2009 |
Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals; Humans; India; Microbial Sensitivity Tests | 2009 |
Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Blood; Cluster Analysis; DNA Fingerprinting; DNA Primers; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Philadelphia; Polymerase Chain Reaction; Respiratory System; Sequence Analysis, DNA; Urine; Wounds and Injuries | 2009 |
Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.
Topics: Anti-Infective Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Imipenem; Longitudinal Studies; Microbial Sensitivity Tests; Population Surveillance | 2010 |
Predominance of CTX-M-type extended-spectrum beta-lactamase genes among enterobacterial isolates from outpatients in Brazil.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Brazil; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Outpatients; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2009 |
Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Citrobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Serratia; Serratia Infections | 2009 |
Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Citrobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Serratia; Serratia Infections | 2009 |
A novel OXA-10-like beta-lactamase is present in different Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Plasmids | 2010 |
Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2010 |
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype | 2010 |
Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Netherlands; Prevalence; Sequence Analysis, DNA | 2010 |
Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA Primers; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA | 2010 |
Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Plasmids; Texas | 2010 |
Carriage of qnrA1 and qnrB2, blaCTX-M15, and complex class 1 integron in a clinical multiresistant Citrobacter freundii isolate.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Catheter-Related Infections; Citrobacter freundii; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Integrons; Male; Molecular Sequence Data; Plasmids; Portugal; Quinolones; Sequence Analysis, DNA | 2010 |
[Comparative study of Vitek-2™ AIX versus Vitek-2™ PC: phenotypic resistance of enterobacteriaceae to β-lactams].
Topics: Anti-Bacterial Agents; Automation, Laboratory; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electronic Data Processing; Enterobacteriaceae Infections; High-Throughput Screening Assays; Humans; Microbial Sensitivity Tests; Models, Biological; Phenotype | 2012 |
Detection of a common plasmid carrying blaKPC-2 in Enterobacteriaceae isolates from distinct cities in China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, Urban; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction | 2010 |
A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2010 |
Emergence of VIM-12 in Enterobacter cloacae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Plasmids | 2010 |
Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Sweden; Young Adult | 2010 |
Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Escherichia coli; Humans; Japan; Klebsiella; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Proteus mirabilis; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA | 2010 |
Frequency of conjugative transfer of plasmid-encoded ISEcp1 - blaCTX-M-15 and aac(6')-lb-cr genes in Enterobacteriaceae at a tertiary care center in Lebanon - role of transferases.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cluster Analysis; Community Health Centers; Conjugation, Genetic; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Gene Transfer, Horizontal; Genotype; Humans; Lebanon; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Transferases | 2010 |
Osteomyelitis after bilateral sagittal split osteotomy: case report and a review of the management.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Bone Plates; Bone Screws; Clindamycin; Drainage; Enterobacteriaceae Infections; Ertapenem; Female; Gram-Negative Bacterial Infections; Humans; Jaw Fixation Techniques; Mandible; Ofloxacin; Open Bite; Orthognathic Surgical Procedures; Osteomyelitis; Osteotomy; Osteotomy, Le Fort; Retrognathia; Streptococcal Infections | 2011 |
Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Boston; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Ertapenem; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome; Urban Population; Young Adult | 2010 |
Citrobacter koseri as a cause of early periprosthetic infection after primary total hip arthroplasty.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; beta-Lactams; Citrobacter koseri; Debridement; Enterobacteriaceae Infections; Ertapenem; Hip Joint; Hip Prosthesis; Humans; Joint Diseases; Male; Middle Aged; Prosthesis-Related Infections; Radiography; Therapeutic Irrigation; Treatment Outcome | 2011 |
Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2011 |
In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Quinolones; Tigecycline | 2011 |
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Follow-Up Studies; Hospitals; Humans; Infant; Male; Pyelonephritis; Recurrence; Retrospective Studies; Turkey; Urinary Tract Infections | 2011 |
Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Child; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, University; Humans; Klebsiella; Microbial Sensitivity Tests | 2011 |
Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France.
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; France; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Morocco | 2011 |
Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
Topics: Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Japan; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcal Infections; Staphylococcus | 2011 |
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Case-Control Studies; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Meropenem; Middle Aged; Risk Factors; Thienamycins | 2011 |
De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.
Topics: Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Critical Care; Decision Trees; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Japan; Male; Middle Aged; Penicillins; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Chromatography, Gel; DNA Primers; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Taq Polymerase; Time Factors; Transition Temperature | 2011 |
Method for phenotypic detection of extended-spectrum beta-lactamases in enterobacter species in the routine clinical setting.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Clinical Laboratory Techniques; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Predictive Value of Tests | 2011 |
Rapid detection of the blaNDM-1 gene by real-time PCR.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA Primers; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Time Factors | 2011 |
Dissemination of the New Delhi metallo-β-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in north India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Random Amplified Polymorphic DNA Technique; Young Adult | 2011 |
Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Boronic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity; Thienamycins | 2011 |
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Cohort Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2012 |
Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009).
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cluster Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Environmental Monitoring; Epidemiological Monitoring; Genetic Variation; Humans; India; Microarray Analysis; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2011 |
Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones; Uruguay | 2011 |
Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacteriaceae Infections; Ertapenem; Humans; Male; Molecular Sequence Data; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Pantoea | 2011 |
bla(CTX-M), bla(TEM), and bla(SHV) in Enterobacteriaceae from North-Indian tertiary hospital: high occurrence of combination genes.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; India; Klebsiella pneumoniae; Polymerase Chain Reaction | 2011 |
Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Health Surveys; Humans; Microbial Sensitivity Tests; Physicians; Prevalence; Public Health | 2011 |
Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.
Topics: beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Poland | 2011 |
Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Italy.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Italy; Microbial Sensitivity Tests | 2011 |
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Mass Screening; Microbial Sensitivity Tests | 2012 |
NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Diabetic Foot; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; India; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Skin Diseases, Bacterial; Ulcer | 2012 |
Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; South Africa | 2012 |
Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cluster Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Gene Expression Profiling; Genotype; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Typing; Reverse Transcriptase Polymerase Chain Reaction; Taiwan | 2012 |
Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Young Adult | 2012 |
Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Gastrointestinal Tract; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests | 2012 |
Study of plasmid-mediated extended-spectrum β-lactamase-producing strains of enterobacteriaceae, isolated from diabetic foot infections in a North Indian tertiary-care hospital.
Topics: Amputation, Surgical; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Diabetic Foot; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gangrene; Genotype; Humans; India; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Risk Factors | 2012 |
Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae.
Topics: Algorithms; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Microbiological Techniques; Phenotype; Sensitivity and Specificity; Sequence Analysis, DNA | 2012 |
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2012 |
In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam.
Topics: Anti-Bacterial Agents; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Taiwan | 2012 |
Emergence of NDM-1-producing Enterobacteriaceae in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Plasmids | 2012 |
Overexpression of mltA in Edwardsiella tarda reduces resistance to antibiotics and enhances lethality in zebra fish.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Edwardsiella tarda; Enterobacteriaceae Infections; Fish Diseases; Gene Deletion; Glycosyltransferases; Real-Time Polymerase Chain Reaction; Virulence; Zebrafish | 2012 |
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult | 2012 |
An evaluation of the Mast D69C AmpC Detection Disc Set for the detection of inducible and derepressed AmpC β-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2012 |
Chromosomal blaCTX-M-₁₅ associated with ISEcp1 in Proteus mirabilis and Morganella morganii isolated at the Military Hospital of Tunis, Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; DNA Transposable Elements; DNA, Bacterial; Enterobacteriaceae Infections; Hospitals, Military; Humans; Microbial Sensitivity Tests; Morganella morganii; Polymerase Chain Reaction; Proteus mirabilis; Tunisia | 2012 |
Risk factors for urinary tract infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase resistance in patients admitted to internal medicine departments.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cohort Studies; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Internal Medicine; Israel; Male; Odds Ratio; Prevalence; Retrospective Studies; Risk Factors; Urinary Tract Infections | 2012 |
Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010.
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans; Microbial Sensitivity Tests | 2012 |
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Linear Models; Meropenem; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Taiwan; Thienamycins | 2012 |
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies | 2012 |
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Thailand | 2012 |
In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
Topics: beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Germany; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Prevalence; Retrospective Studies; Tigecycline | 2012 |
Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards.
Topics: Adolescent; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Cluster Analysis; Cross Infection; Czech Republic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Fluoroquinolones; Genotype; Hospitals, Pediatric; Humans; Multilocus Sequence Typing; Neoplasms; Plasmids | 2012 |
Comparison of different phenotypic assays for the detection of extended-spectrum β-lactamase production by inducible AmpC-producing Gram-negative bacilli.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2013 |
Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Thienamycins; Treatment Outcome | 2013 |
Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests | 2002 |
Extended-spectrum beta-lactamases in Enterobacteriaceae: related to age and gender.
Topics: Adult; Age Factors; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pakistan; Sex Factors | 2002 |
[Urinary tract infections due to wide spectrum beta lactamase producing enterobacteriaceae].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Geriatrics; Hospital Departments; Humans; Length of Stay; Male; Recurrence; Survival Rate; Treatment Failure; Urinary Tract Infections | 2002 |
[Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Escherichia coli; Humans; Inhibitory Concentration 50; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2002 |
Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of enterobacter species in Korea.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Enterobacter; Enterobacteriaceae Infections; Humans; Isoelectric Focusing; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sequence Analysis, DNA | 2003 |
Diversity of chromosomal AmpC beta-lactamases from Enterobacter cloacae isolates in a Portuguese hospital.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Chromosomes, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genetic Variation; Genotype; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Portugal; Prevalence; Transformation, Bacterial | 2004 |
Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Conjugation, Genetic; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Plasmids; Random Amplified Polymorphic DNA Technique | 2004 |
In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Genes, Bacterial; Humans; Lactams; Microbial Sensitivity Tests; Urinary Tract Infections | 2004 |
Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Colony Count, Microbial; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Sequence Analysis, DNA; Thienamycins | 2004 |
Effect of ertapenem protein binding on killing of bacteria.
Topics: Bacteria; beta-Lactams; Chromatography, High Pressure Liquid; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Humans; Indicators and Reagents; Kinetics; Lactams; Microbial Sensitivity Tests; Protein Binding; Regression Analysis; Spectrophotometry, Ultraviolet; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; India; Microbial Sensitivity Tests; Prevalence | 2004 |
Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Hospitalization; Humans; Microbial Sensitivity Tests; Prevalence; Spain; Time Factors | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2004 |
Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; China; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2005 |
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
Topics: Acetyltransferases; Aged; Amino Acid Sequence; Bacteremia; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Greece; Humans; Imipenem; Integrons; Lactams; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction | 2005 |
High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
Topics: beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Microbial Sensitivity Tests; Plasmids | 2005 |
Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunodiffusion; Microbial Sensitivity Tests | 2005 |
Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Citrobacter freundii; Enterobacter aerogenes; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Hospitals, University; Humans; Microbial Sensitivity Tests; Paris; Proteus mirabilis | 2005 |
Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Slovakia | 2005 |
Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lebanon; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2005 |
Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Computer Simulation; Enterobacteriaceae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Monte Carlo Method; Regression Analysis | 2005 |
Extended-spectrum beta-lactamase-conferring transferable resistance to different antimicrobial agents in Enterobacteriaceae isolated from bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2005 |
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Risk Factors; Urinary Tract Infections | 2005 |
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries | 2006 |
[New beta-lactamases in enterobacteriaceae. The Danish Society of Clinical Microbiology].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2006 |
Beta-lactamases in Enterobacteriaceae--an ever-present threat.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Colony Count, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques | 2006 |
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2006 |
Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalexin; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Genotype; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results; Sequence Analysis, DNA | 2007 |
Molecular characterization of extended-spectrum beta-lactamases in Enterobacteriaceae from patients of two hospitals in Saxony, Germany.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA Fingerprinting; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Hospitals; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 2007 |
Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital.
Topics: Amino Acid Substitution; beta-Lactamases; beta-Lactams; Chromatography, Gel; Chromatography, Ion Exchange; Citrobacter koseri; Cloning, Molecular; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Isoelectric Focusing; Italy; Kinetics; Models, Molecular; Recombinant Proteins; Substrate Specificity | 2007 |
Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; France; Microbial Sensitivity Tests; Molecular Epidemiology; Prevalence | 2008 |
First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Fluoroquinolones; Hospitals; Humans; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
[Estimation of the contribution of the small plasmids in creation of ESBL phenotype among clinical and ambulatory isolates of the Enterobacteriaceae].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; F Factor; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2007 |
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Topics: Adult; Anti-Bacterial Agents; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Spain; Urine | 2007 |
Living with ESBLs. Introduction.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Microbial Sensitivity Tests; Mutation | 2008 |
Multidrug-resistant Escherichia fergusonii: a case of acute cystitis.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Cystitis; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Urine | 2008 |
Proceedings of the ESCMID Conference on Extended-spectrum Beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Mutation | 2008 |
Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria.
Topics: Algeria; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA | 2008 |
Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Gene Expression Regulation, Bacterial; Genes, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests | 2008 |
Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Data Collection; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Molecular Epidemiology; Molecular Sequence Data; Poland | 2008 |
First detection of plasmid-mediated, quinolone resistance determinants qnrA, qnrB, qnrS and aac(6')-Ib-cr in extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in Budapest, Hungary.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Hungary; Plasmids; Quinolones | 2008 |
Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blood; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Sputum; Suppuration; Urine | 2008 |
Extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bulgarian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Bulgaria; DNA Fingerprinting; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Plasmids; Random Amplified Polymorphic DNA Technique | 2008 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Treatment of acute bacterial meningitis with special emphasis on beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Enterobacteriaceae Infections; Humans; Meningitis; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal | 1984 |
Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Diffusion; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Hydrolysis; Male; Microbial Sensitivity Tests; Middle Aged; Mutation | 1983 |
Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Porins; Quinolones | 1998 |
TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; DNA, Bacterial; Enterobacteriaceae Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Providencia | 1999 |
Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.
Topics: Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Enterobacter; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2000 |
Spectrum and transferability of beta-lactam resistance in hospital strains of Enterobacter isolated in Bratislava and Innsbruck.
Topics: Anti-Bacterial Agents; Austria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Plasmids; Slovakia | 2000 |
Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Conjugation, Genetic; Cross Infection; Electroporation; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Humans; Integrases; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Thailand | 2001 |
Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Plasmids | 2001 |
Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Blood; Enterobacteriaceae Infections; Escherichia coli; Feces; Humans; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Shigella sonnei | 2001 |
Occurrence and transferability of beta-lactam resistance in Enterobacteriaceae isolated in Children's University Hospital in Bratislava.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Child, Preschool; Conjugation, Genetic; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Plasmids; Slovakia | 2001 |
Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacter aerogenes; Enterobacter cloacae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Spain | 2002 |
TEM-80, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Enterobacter cloacae.
Topics: Aged; Aged, 80 and over; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2002 |
Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France.
Topics: Anti-Bacterial Agents; beta-Lactams; Data Collection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; France; Humans; Laboratories, Hospital; Prevalence | 2002 |
A new beta-lactam antibiotic: is it a major advance?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefoxitin; Enterobacteriaceae Infections; Humans | 1979 |
Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacter cloacae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Species Specificity | 1992 |
Screening method for beta-lactamase substrate profiles.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Klebsiella; Klebsiella Infections; Methods; Pseudomonas; Reproducibility of Results; Substrate Specificity | 1992 |
[Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Child; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Phenotype; Proteus mirabilis; Salmonella | 1991 |
Isolation of Enterobacter aerogenes susceptible to beta-lactam antibiotics despite high level beta-lactamase production.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Meningitis; Middle Aged | 1990 |
Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models.
Topics: 4-Quinolones; Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Disease Models, Animal; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Least-Squares Analysis; Mice; Mice, Inbred ICR; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms | 1990 |
Multiply beta-lactam resistant Enterobacter cloacae infections linked to the environmental flora in a unit for cardiothoracic and vascular surgery.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cardiac Surgical Procedures; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Departments; Humans; Male; Middle Aged; Operating Rooms; Sepsis; Serotyping; Surgery Department, Hospital; Surgical Wound Infection; Vascular Surgical Procedures | 1989 |
How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection?
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Body Fluids; Culture Media; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1989 |
[Failure of new beta-lactam antibiotics in the treatment of severe Enterobacter cloacae infections].
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Child; Enterobacter; Enterobacteriaceae Infections; Female; Genetic Variation; Humans; Male; Middle Aged; Mutation; Penicillin Resistance | 1986 |